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ABSTRACT 
Wegener’s vasculitis is an autoimmune 
disease affecting small and medium-sized 
blood vessels with a high mortality rate. 
It is a disease of usually subsidious course 
and nonspecific initial symptoms that are 
diagnostically misleading. Cardiac in-
volvement is described most frequently in 
the form of supraventricular tachyarrhyt-
mias, and rarely as a clinically significant 
myocardial infarction. This case demon-
strates another facet of this disease pre-
senting as full blown shock and respiratory 
insufficiency progressing to ARDS (acute 
respiratory distress syndrome) and multi-
organ failure over the course of two weeks, 
with an unfortunately fatal outcome.
INTRODUCTION
Wegener’s granulomatosis is a rare multi-
system autoimmune disease of unknown 
etiology. It is characterised by necrotizing 
granulomatous inflammation and pauci-
immune vasculitis in small- and medi-
um-sized blood vessels. It predominantly 
affects the upper and lower respiratory 
tract and the kidneys, but can potentially 
affect any organ system. It is diagnosed 
by clinical features, immunology assays 
(anti-neutrophil cytoplasmic antibodies) 
and histology. Before the institution of ef-
fective therapy, the mean survival of adults 
with untreated GPA was only 5 months, 
with 82% of patients dying within the first 
year and 90% of patients dying within the 
second year. (1) Despite improvements 
with the use of corticosteroids, the mean 
survival time was increased to only 12.5 
months. (1) Cardiac involvement occurs in 
6 to 44% of cases. (2) The most frequent 
clinical manifestation are cardiac arrhyth-
mias that are manifested as supraventricu-
lar tachyarrhythmias. We report a case of 
Wegener’s vasculitis that manifested at 
admission as fulminant cardiogenic shock 
with multisystem failure and complete 
heart block.
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CASE REPORT
A 58-year-old female patient presented to 
the emergency department (ED) with syn-
cope lasting for several seconds. Two weeks 
before presenting to the ED she had some 
haemoptysis and reported to the respira-
tory clinic. She complained of lethargy and 
fatigue during the last month long period. 
Pulmonary x-ray showed discrete, bilateral 
pulmonary infiltrates. The patient was di-
agnosed with bilateral pneumonia and oral 
cefpodoxim was prescribed. On the fifth 
day of antibiotic therapy she experienced 
nausea, retrosternal pain, vomited once 
and had syncope. The patient was admit-
ted to the coronary care unit. Her medical 
history included: arterial hypertension, 
myocardial infarction in 2006, hyperlip-
demia, and phlebothrombosis in 2014. 
Her medications included: warfarine, tri-
metazidine, amiodarone, isosorbide mon-
onitrate, ramipril+hydrochlorothiazide, 
lacipidine. Physical examination showed 
pale skin, bilateral inspiratory crackles and 
a venous ulcer on her left lower leg. A 12-
lead electrocardiogram showed a new left 
bundle branch block. The bedside ECHO 
demonstrated slightly dilated left heart 
chambers with reduced systolic function of 
the left ventricle measuring 30%, including 
inferior posterior wall hypokinesis. Right 
ventricle function was normal. Repeated 
laboratory tests showed an inflammatory 
response with leukocytosis of 15.91x109/
μL with a leftward shift, elevated C-reac-
tive protein of 101 mg/L, severe anaemia 
and elevated cardioselective enzymes. The 
findings were consistent with multi-organ 
dysfunction and metabolic acidosis. Chest 
X-ray showed bilateral lung alveolar in-
filtrates (figure 1) that progressed rapidly 
over the course of a few hours and were 
consistent with adult respiratory distress 
syndrome (figure 2). In time, gradual 
hemodynamic deterioration required the 
combined use of vasopressors and ino-
tropes, and continuous renal replacement 
therapy in parallel with an empirical broad 
spectrum antibiotic. The entire treatment 
lasted less than 48 hours. Although im-
munology assays weren’t complete in such 
a short period, the overall clinical context 
suggested a possible autoimmune disease, 
so an ex iuvantibus pulse dose of corticos-
teroids was applied (methylprednisolone 
1g). The respiratory and hemodynamic 
functions deteriorated rapidly, resulting 
in the patient being transferred to another 
centre for extracorporeal membrane oxy-
genation therapy (ECMO). However, the 
patient died before the therapy could be 
initiated. Afterwards, the elevated C-AN-
CA of 98.7 confirmed the diagnosis of We-
gener’s granulomatosis. 
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Figure 1. Bilateral, discrete pulmonary in-
filtrates
Figure 2. Bilateral pulmonary infiltrates 
– ARDS (Acute respiratory distress syn-
drome)
DISCUSSION
Wegener’s patients typically present with 
constitutional, low intensity symptoms 
including fever, migratory arthralgias, ma-
laise, anorexia and weight loss. Prodromal 
symptoms may last for weeks to months 
without evidence of specific organ involve-
ment. (4) Significant cardiac complications 
occurring during the course of Wegener’s 
granulomatosis are rare. (5) Cardiac in-
volvement is rarely detected antemortem 
but includes pericarditis and coronary 
arteritis in 10-20% of cases. (5) Necrotiz-
ing vasculitis of the coronary vessels can 
result in a myocardial infarction or sudden 
death. (6) Clinically significant myocardial 
infarction is extremely rare in Wegener’s 
granulomatosis. (6) A comprehensive re-
view of 158 patients reported that 10 (6%) 
developed pericarditis, eight of whom had 
typical clinical symptoms and signs. (6) An 
especially rare presentation is cardiogenic 
shock. Frequently, pulmonary involve-
ment is more severe or fulminant. Our 
patient presented with cardiogenic shock 
and fulminant respiratory failure of un-
known etiology and was refractory to all 
conservative treatments. The first working 
diagnosis on admission was acute coro-
nary syndrome, but bilateral pulmonary 
infiltrates and haemoptysis rose suspicion 
for vasculitis as a primary diagnosis and 
intravenous corticosteroids were given in 
parallel with all other applied measures. 
However, the clinical response was imper-
ceptible. An ECMO procedure was indi-
cated and the patient was transported to 
the national centre.
CONCLUSION
Antineutrophil cytoplasmic antibody 
(ANCA)-associated vasculitides in-
clude granulomatosis with polyangiitis 
(GPA), microscopic polyangiitis (MPA), 
the Churg-Strauss syndrome (CSS), and 
renal-limited vasculitis. All are associ-
ated with antineutrophil cytoplasmic an-
tibodies (ANCA). (4) Clinical signs and 
symptoms are non-specific and diagnosis 
is a real challenge for physicians as it can 
be difficult to distinguish the signs and 
symptoms from other common diseases, 
such as infection or malignancy. The ful-
minant form of the disease is not common, 
but in such cases a rapid diagnostic evalu-
ation and therapeutic strategy is of vital 
importance. In our case the course of the 
disease was abrupt and fulminant; it began 
with pulmonary infiltrates and haemopty-
sis that were misdiagnosed as pneumonia, 
and over the course of the next two weeks 
it progressed to ARDS and cardiogenic 
shock with multi-organ dysfunction syn-
drome. The patient was unfortunately in 
an irreversible stage of the disease and was 
refractory to all undertaken measures.
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